Drug Eluting Stents
What we do and how we do it
Ultimaster™ Tansei™
- Sirolimus Eluting Coronary Stent System
- Innovative abluminal bioresorbable coating
- Drug coating applied in a gradient to reduce the risk of polymer cracking and delamination, even when the stent is overexpanded
- PCL added to PDLLA, increasing the elasticity of the bioresorbable polymer coating
- Simultaneous polymer resorption and drug release within 3–4 months, to match the procedure-triggered biological response
- No drug coating on parts of the stent that experience the most physical stress.
Make Inquiry
Kindly consider giving us an opportunity to offer lasting solutions to your esteemed organization, through provision of timely and reliable service.
